
Triventures is a global venture capital fund founded in 2010 that invests in early-stage, data-driven companies across healthcare and beyond, including digital health, medical devices, fintech, cybersecurity, and e-commerce. It was the first Israeli VC to focus on data-driven healthcare solutions and has offices in Israel and Silicon Valley.
58% of their portfolio is in Healthcare. Average disclosed round size is $25.0M (across 33 rounds with reported amounts).
Portfolio
23
Fund Size
$125M
Top Stage
Series C
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
33 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Growth | $50M | Dec 2024 | |
| Series A | $27M | Oct 2024 | |
| BBrightside Health | Series C | $33M | Mar 2024 |
| Series A | $19.7M | Nov 2023 | |
| BBIOPROTECT LTD | Unknown | $28M | Sep 2023 |
| Seed | $5.9M | Jul 2023 | |
| Series B | $9M | Oct 2022 | |
| Series B | $25M | Apr 2022 | |
| Series B | $50M | Jan 2022 | |
| Seed | $11M | Jun 2021 | |
| Series C | $25M | Mar 2021 | |
| Series C | $30M | Feb 2021 | |
| Series C | $50M | Jan 2021 | |
| Series C | $98M | Sep 2020 | |
| Series A | $35.1M | Jan 2020 | |
| Series C | $50M | Jan 2019 | |
| Series B | $22M | Jan 2017 | |
| Series D | $30M | Jan 2017 | |
| Series B | $28M | Jan 2016 | |
| Unknown | $40M | — | |
| Unknown | $8M | — | |
| Seed | $12M | — | |
| Series B | $6.5M | — | |
| Series A | $15.6M | — | |
| Seed | $1.5M | — |
Page 1 of 2
Top Co-Investors
Pontifax7 shared
ACME Capital4 shared
Action Potential Venture Capital3 shared
GV3 shared
Lightstone Ventures3 shared
Lux Capital3 shared
Qualcomm Ventures3 shared
S323 shared
Time BioVentures3 shared
Mousse Partners3 shared
Western Technology Investment3 shared
Bullpen Capital3 shared
Ascension Ventures2 shared
PEAK6 Strategic Capital2 shared
OurCrowd2 shared
Alter Global2 shared
Samsung Next2 shared
Planven Entrepreneur Ventures2 shared
Singtel Innov82 shared
Telefonica2 shared
Last updated: 7 October 2026